WAY TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS WITH  GENETIC ENGINEERED BIOLOGICAL DRUGS

Please use this identifier to cite or link to this item: http://repo.tma.uz/xmlui/handle/1/143

Full metadata record

DC Field	Value	Language
dc.contributor.author	Mallaev Sh. Sh. Egamberdiev S. B. Mukhtorov M. G.	-
dc.date.accessioned	2024-11-21T09:02:01Z	-
dc.date.available	2024-11-21T09:02:01Z	-
dc.date.issued	2024	-
dc.identifier.uri	http://repo.tma.uz/xmlui/handle/1/143	-
dc.description.abstract	The article describes the clinical and immunological features of juvenile idiopathic arthritis in children. Clinical features of the disease, laboratory analysis results are important when choosing an effective treatment method. An effective treatment method is characterized by a faster onset of remission, prolongation of its duration and reduction of side effects of drug treatment.	en_US
dc.language.iso	en_US	en_US
dc.publisher	Web of Scientist: International Scientific Research Journal	en_US
dc.subject	juvenile idiopathic arthritis, prognosis, biological drugs	en_US
dc.title	WAY TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS WITH GENETIC ENGINEERED BIOLOGICAL DRUGS	en_US
dc.type	Article	en_US
Appears in Collections:	Articles

Files in This Item:

File	Description	Size	Format
sanjar WAY TREATMENT OF JUVENILE . nov.-2024.pdf	WAY TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS WITH GENETIC ENGINEERED BIOLOGICAL DRUGS	561.74 kB	Adobe PDF	View/Open

DSpace JSPUI